[Dynamic detection of regulatory T cells in murine mammary carcinoma model and its significance].
Hongmei Zhu, Ting Hu, Mei Fang Yang, He Wang, Xinlian Chen, Xiaoyan Xie, Shanling Liu
Abstract
Hongmei Zhu, Ting Hu, Mei Fang Yang, He Wang, Xinlian Chen, Xiaoyan Xie, Shanling Liu
Abstract
OBJECTIVE: To analyze the dynamic change of regulatory T cells in experimental murine mammary carcinoma model, and to investigate their effect on tumor progress. METHODS: Mouse mammary carcinoma models were established. The percentages of CD4+ CD25+ and CD4+ FOXP3+ regulatory T cells in the CD4+ T cells in tumor tissue, tumor draining lymph node and spleen were measured by FACS at 3 different time points after tumor challenge. The expression of CD25+ FOXP3 in CD4+ T cells was analyzed, and the expression of CD4+ T cells in T cells (CD3+) of tumor tissue. RESULTS: Compared with the normal control group, In mouse mammary carcinoma models, The percentages of CD4+ T cells to lymphocytes in lymph node and spleen were decreased in the late stage (P<0.05). The percentages of CD4+ CD25+ and CD4+ FOXP3+ regulatory T cells in the CD4+ T cells were markedly increased (P<0.05), The percentages of CD25+ FOXP3+ regulatory T cells in the CD4+ T cells were markedly increased also (P<0.05). In the tumor tissue, the percentages of CD4+ T cells and CD4+ CD25+ regulatory T cells in T cells (CD3+) were increased in three weeks after the tumor challenge than one week (P< 0. 05). The percentages of CD4+ CD25+ and CD4+ FOXP3+ regulatory T cells in the CD4+ T cells have no change between one week and three weeks after tumor planting (P>0.05). CONCLUSION: Regulatory T cells were significantly increased in malignant tumor model, and closely related to the development of tumor.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To analyze the dynamic change of regulatory T cells in experimental murine mammary carcinoma model, and to investigate their effect on tumor progress. METHODS: Mouse mammary carcinoma models were established. The percentages of CD4+ CD25+ and CD4+ FOXP3+ regulatory T cells in the CD4+ T cells in tumor tissue, tumor draining lymph node and spleen were measured by FACS at 3 different time points after tumor challenge. The expression of CD25+ FOXP3 in CD4+ T cells was analyzed, and the expression of CD4+ T cells in T cells (CD3+) of tumor tissue. RESULTS: Compared with the normal control group, In mouse mammary carcinoma models, The percentages of CD4+ T cells to lymphocytes in lymph node and spleen were decreased in the late stage (P<0.05). The percentages of CD4+ CD25+ and CD4+ FOXP3+ regulatory T cells in the CD4+ T cells were markedly increased (P<0.05), The percentages of CD25+ FOXP3+ regulatory T cells in the CD4+ T cells were markedly increased also (P<0.05). In the tumor tissue, the percentages of CD4+ T cells and CD4+ CD25+ regulatory T cells in T cells (CD3+) were increased in three weeks after the tumor challenge than one week (P< 0. 05). The percentages of CD4+ CD25+ and CD4+ FOXP3+ regulatory T cells in the CD4+ T cells have no change between one week and three weeks after tumor planting (P>0.05). CONCLUSION: Regulatory T cells were significantly increased in malignant tumor model, and closely related to the development of tumor.
Key concepts: FOXP3, IL-2 receptor, Spleen, Lymph node, Biology, Regulatory T cell, Interleukin 21, Mammary tumor